SE448233B - 1,2,4-triazolderivat, forfarande for framstellning derav och farmaceutisk komposition - Google Patents

1,2,4-triazolderivat, forfarande for framstellning derav och farmaceutisk komposition

Info

Publication number
SE448233B
SE448233B SE8101311A SE8101311A SE448233B SE 448233 B SE448233 B SE 448233B SE 8101311 A SE8101311 A SE 8101311A SE 8101311 A SE8101311 A SE 8101311A SE 448233 B SE448233 B SE 448233B
Authority
SE
Sweden
Prior art keywords
group
alkyl
formula
methyl
compounds
Prior art date
Application number
SE8101311A
Other languages
English (en)
Swedish (sv)
Other versions
SE8101311L (sv
Inventor
J W Clitherow
J Bradshaw
J W M Mackinnon
D B Judd
D E Bays
R Hayes
A Pearce
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8101311L publication Critical patent/SE8101311L/xx
Publication of SE448233B publication Critical patent/SE448233B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
SE8101311A 1980-02-28 1981-02-27 1,2,4-triazolderivat, forfarande for framstellning derav och farmaceutisk komposition SE448233B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8006806 1980-02-28

Publications (2)

Publication Number Publication Date
SE8101311L SE8101311L (sv) 1981-08-29
SE448233B true SE448233B (sv) 1987-02-02

Family

ID=10511754

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8101311A SE448233B (sv) 1980-02-28 1981-02-27 1,2,4-triazolderivat, forfarande for framstellning derav och farmaceutisk komposition

Country Status (26)

Country Link
US (1) US4670448A (de)
JP (2) JPS56147777A (de)
KR (3) KR850000668B1 (de)
AT (2) AT380240B (de)
AU (1) AU544357B2 (de)
BE (1) BE887730A (de)
CA (1) CA1158649A (de)
CH (1) CH655104A5 (de)
CY (1) CY1335A (de)
DE (1) DE3107628A1 (de)
DK (1) DK90681A (de)
ES (4) ES499931A0 (de)
FI (1) FI76076C (de)
FR (1) FR2477150A1 (de)
GB (1) GB2075007B (de)
HK (1) HK69186A (de)
IE (1) IE50987B1 (de)
IL (1) IL62229A (de)
IT (1) IT1209846B (de)
KE (1) KE3629A (de)
MY (1) MY8500428A (de)
NL (2) NL186812C (de)
NO (1) NO810681L (de)
NZ (1) NZ196365A (de)
SE (1) SE448233B (de)
ZA (1) ZA811331B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57169452A (en) * 1981-04-14 1982-10-19 Teikoku Hormone Mfg Co Ltd Novel phenoxyalkylamide derivative
AU8480982A (en) * 1981-06-11 1983-01-13 Glaxo Group Limited 1,2,4-triazole derivatives with histamine h2-blocking activity
PT76280A (en) * 1982-02-24 1983-03-01 Glaxo Group Ltd Process for preparing heterocyclic derivatives
CA1189508A (en) * 1982-02-25 1985-06-25 Roger Hayes Heterocyclic derivatives as histamine h.sub.2- antagonists
GB8417194D0 (en) * 1984-07-05 1984-08-08 Boots Co Plc Therapeutic agents
GB8628475D0 (en) * 1986-11-28 1987-01-07 Glaxo Group Ltd Medicaments
GB8805268D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
JP3328082B2 (ja) * 1994-12-13 2002-09-24 日本カーバイド工業株式会社 Ｎ−グアニジノチオ尿素塩及び３−アミノ−５−メルカプト−１，２，４−トリアゾールの製造方法
WO2001024796A1 (en) * 1999-10-01 2001-04-12 Smithkline Beecham Corporation 1,2,4-triazole derivatives, composition, process of making and methods of use
JP4564786B2 (ja) * 2004-06-07 2010-10-20 株式会社日本ファインケム １−置換―１―アミノグアニジン又はその塩、及びこれらの製造方法
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
GB2023133B (en) * 1978-04-26 1982-09-08 Glaxo Group Ltd Heterocyclic derivatives
AR228941A1 (es) * 1978-04-26 1983-05-13 Glaxo Group Ltd Procedimiento para preparar nuevos derivados de 3,5-diamino-1,2,4-triazol que son activos contra receptores histaminicos
DK89480A (da) * 1979-03-02 1980-09-03 Glaxo Group Ltd R fremgangsmaade til fremstilling af heterocycliske forbindelse

Also Published As

Publication number Publication date
DE3107628C2 (de) 1991-03-14
FR2477150B1 (de) 1984-03-16
IE50987B1 (en) 1986-09-03
ES8304954A1 (es) 1983-03-16
NZ196365A (en) 1984-07-31
IE810431L (en) 1981-08-28
KR850002010A (ko) 1985-04-10
ES518305A0 (es) 1984-06-16
DK90681A (da) 1981-08-29
HK69186A (en) 1986-09-26
KR830005164A (ko) 1983-08-03
MY8500428A (en) 1985-12-31
ES8205208A1 (es) 1982-06-01
ES8405775A1 (es) 1984-06-16
AT387774B (de) 1989-03-10
IL62229A0 (en) 1981-03-31
ATA93981A (de) 1985-09-15
GB2075007B (en) 1983-07-13
KR850000682B1 (ko) 1985-05-14
FI76076C (fi) 1988-09-09
IL62229A (en) 1987-10-30
JPH0338269B2 (de) 1991-06-10
AU544357B2 (en) 1985-05-23
KR850000676B1 (ko) 1985-05-10
NO810681L (no) 1981-08-31
ATA151084A (de) 1988-08-15
KR850002011A (ko) 1985-04-10
FI76076B (fi) 1988-05-31
SE8101311L (sv) 1981-08-29
IT1209846B (it) 1989-08-30
FI810619L (fi) 1981-08-29
GB2075007A (en) 1981-11-11
ES509669A0 (es) 1983-03-16
JPS6452763A (en) 1989-02-28
KR850000668B1 (ko) 1985-05-09
NL8802221A (nl) 1989-01-02
CA1158649A (en) 1983-12-13
DE3107628A1 (de) 1982-04-01
NL186812B (nl) 1990-10-01
FR2477150A1 (fr) 1981-09-04
KE3629A (en) 1986-05-16
ES530741A0 (es) 1985-07-01
IT8147905A0 (it) 1981-02-27
BE887730A (fr) 1981-08-27
CH655104A5 (fr) 1986-03-27
JPS56147777A (en) 1981-11-16
NL186812C (nl) 1991-03-01
CY1335A (en) 1986-10-24
US4670448A (en) 1987-06-02
ZA811331B (en) 1982-10-27
NL8100979A (nl) 1981-10-01
AU6793381A (en) 1981-09-03
ES499931A0 (es) 1982-06-01
AT380240B (de) 1986-04-25
ES8506292A1 (es) 1985-07-01

Similar Documents

Publication Publication Date Title
US7452899B2 (en) Gamma-secretase inhibitors
US4318913A (en) 1,2,4-Triazole-3,5-diamine derivatives
FR2764889A1 (fr) Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
EP0883613A1 (de) Sulfonamidederivate als 5ht7 rezeptor antagonist
SE448233B (sv) 1,2,4-triazolderivat, forfarande for framstellning derav och farmaceutisk komposition
KR840000420B1 (ko) 헤로테고리 유도체의 제조방법
KR850001318B1 (ko) 1h-1,2,4-트리아졸 유도체의 제조방법
US4481199A (en) 1,2,4-Triazole-3-amine and 1,2,4 triazole-3,5-diamine compounds and their pharmaceutical use
AU712059B2 (en) Piperazine, piperidine and tetrahydropyridine derivatives
KR840001775B1 (ko) 헤테로 사이클릭 유도체의 제조방법
US4536508A (en) Triazoleamine derivatives having histamine H2 -antagonist properties
US4476126A (en) 1,2,4 Triazoze amines and their pharmaceutical use
US4777179A (en) Heterocyclic derivatives, processes for the use thereof and pharmaceutical compositions containing them
US4482552A (en) Triazole compounds and their pharmaceutical use
KR840001773B1 (ko) 헤테로사이클릭 유도체의 제조방법
IE48750B1 (en) Heterocyclic derivatives
GB2080791A (en) 1,4-Benzoxazines
EP0071434A2 (de) Heterocyclische Derivate
NZ203384A (en) Heterocyclic compounds and pharmaceutical compositions
GB2063875A (en) Heterocyclic derivatives: Processes for the production thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8101311-2

Effective date: 19910911

Format of ref document f/p: F